104 related articles for article (PubMed ID: 7944407)
1. Purification of biologically active SPARC expressed in Saccharomyces cerevisiae.
Yost JC; Bell A; Seale R; Sage EH
Arch Biochem Biophys; 1994 Oct; 314(1):50-63. PubMed ID: 7944407
[TBL] [Abstract][Full Text] [Related]
2. Expression and purification of recombinant human SPARC produced by baculovirus.
Bradshaw AD; Bassuk JA; Francki A; Sage EH
Mol Cell Biol Res Commun; 2000 Jun; 3(6):345-51. PubMed ID: 11032756
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of endothelial cell proliferation by SPARC is mediated through a Ca(2+)-binding EF-hand sequence.
Sage EH; Bassuk JA; Yost JC; Folkman MJ; Lane TF
J Cell Biochem; 1995 Jan; 57(1):127-40. PubMed ID: 7721952
[TBL] [Abstract][Full Text] [Related]
4. Loss of insulin-like growth factor I receptor-dependent expression of p107 and cyclin A in cells that lack the extracellular matrix protein secreted protein acidic and rich in cysteine.
Basu A; Rodeck U; Prendergast GC; Howe CC
Cell Growth Differ; 1999 Nov; 10(11):721-8. PubMed ID: 10593648
[TBL] [Abstract][Full Text] [Related]
5. Expression of biologically active human SPARC in Escherichia coli.
Bassuk JA; Baneyx F; Vernon RB; Funk SE; Sage EH
Arch Biochem Biophys; 1996 Jan; 325(1):8-19. PubMed ID: 8554346
[TBL] [Abstract][Full Text] [Related]
6. SPARC regulates TGF-beta1-dependent signaling in primary glomerular mesangial cells.
Francki A; McClure TD; Brekken RA; Motamed K; Murri C; Wang T; Sage EH
J Cell Biochem; 2004 Apr; 91(5):915-25. PubMed ID: 15034927
[TBL] [Abstract][Full Text] [Related]
7. An in vitro model of posterior capsular opacity: SPARC and TGF-beta2 minimize epithelial-to-mesenchymal transition in lens epithelium.
Gotoh N; Perdue NR; Matsushima H; Sage EH; Yan Q; Clark JI
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4679-87. PubMed ID: 17898292
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of SPARC and cationic SPARC peptides on DNA synthesis by endothelial cells and fibroblasts.
Funk SE; Sage EH
J Cell Physiol; 1993 Jan; 154(1):53-63. PubMed ID: 8419407
[TBL] [Abstract][Full Text] [Related]
9. Porcine SPARC: isolation from dentin, cDNA sequence, and computer model.
Chun YH; Yamakoshi Y; Kim JW; Iwata T; Hu JC; Simmer JP
Eur J Oral Sci; 2006 May; 114 Suppl 1():78-85; discussion 93-5, 379-80. PubMed ID: 16674666
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of extracellular proteins is correlated with angiogenesis in vitro.
Iruela-Arispe ML; Hasselaar P; Sage H
Lab Invest; 1991 Feb; 64(2):174-86. PubMed ID: 1705300
[TBL] [Abstract][Full Text] [Related]
11. SPARC regulates cell cycle progression in mesangial cells via its inhibition of IGF-dependent signaling.
Francki A; Motamed K; McClure TD; Kaya M; Murri C; Blake DJ; Carbon JG; Sage EH
J Cell Biochem; 2003 Mar; 88(4):802-11. PubMed ID: 12577314
[TBL] [Abstract][Full Text] [Related]
12. Neuroblastoma angiogenesis is inhibited with a folded synthetic molecule corresponding to the epidermal growth factor-like module of the follistatin domain of SPARC.
Chlenski A; Liu S; Baker LJ; Yang Q; Tian Y; Salwen HR; Cohn SL
Cancer Res; 2004 Oct; 64(20):7420-5. PubMed ID: 15492265
[TBL] [Abstract][Full Text] [Related]
13. SPARC/osteonectin induces matrix metalloproteinase 2 activation in human breast cancer cell lines.
Gilles C; Bassuk JA; Pulyaeva H; Sage EH; Foidart JM; Thompson EW
Cancer Res; 1998 Dec; 58(23):5529-36. PubMed ID: 9850090
[TBL] [Abstract][Full Text] [Related]
14. Expression of recombinant membrane-bound type I iodothyronine deiodinase in yeast.
Kuiper GG; Klootwijk W; Visser TJ
J Mol Endocrinol; 2005 Jun; 34(3):865-78. PubMed ID: 15956354
[TBL] [Abstract][Full Text] [Related]
15. The C-terminal Ca2+-binding domain of SPARC confers anti-spreading activity to human urothelial cells.
Delostrinos CF; Hudson AE; Feng WC; Kosman J; Bassuk JA
J Cell Physiol; 2006 Jan; 206(1):211-20. PubMed ID: 16121393
[TBL] [Abstract][Full Text] [Related]
16. Structural variability of BM-40/SPARC/osteonectin glycosylation: implications for collagen affinity.
Kaufmann B; Müller S; Hanisch FG; Hartmann U; Paulsson M; Maurer P; Zaucke F
Glycobiology; 2004 Jul; 14(7):609-19. PubMed ID: 15044389
[TBL] [Abstract][Full Text] [Related]
17. Type I collagen-deficient Mov-13 mice do not retain SPARC in the extracellular matrix: implications for fibroblast function.
Iruela-Arispe ML; Vernon RB; Wu H; Jaenisch R; Sage EH
Dev Dyn; 1996 Oct; 207(2):171-83. PubMed ID: 8906420
[TBL] [Abstract][Full Text] [Related]
18. Regulation of human monocyte matrix metalloproteinases by SPARC.
Shankavaram UT; DeWitt DL; Funk SE; Sage EH; Wahl LM
J Cell Physiol; 1997 Dec; 173(3):327-34. PubMed ID: 9369945
[TBL] [Abstract][Full Text] [Related]
19. Enhanced angiogenesis characteristic of SPARC-null mice disappears with age.
Reed MJ; Bradshaw AD; Shaw M; Sadoun E; Han N; Ferara N; Funk S; Puolakkainen P; Sage EH
J Cell Physiol; 2005 Sep; 204(3):800-7. PubMed ID: 15795937
[TBL] [Abstract][Full Text] [Related]
20. Use of chemical chaperones in the yeast Saccharomyces cerevisiae to enhance heterologous membrane protein expression: high-yield expression and purification of human P-glycoprotein.
Figler RA; Omote H; Nakamoto RK; Al-Shawi MK
Arch Biochem Biophys; 2000 Apr; 376(1):34-46. PubMed ID: 10729188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
